HomeALZN โข NASDAQ
add
Alzamend Neuro Inc
Previous close
$2.02
Year range
$1.69 - $10.71
Market cap
7.68M USD
Avg Volume
80.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Revenue | โ | โ |
Operating expense | 998.11K | -26.51% |
Net income | -1.00M | 26.50% |
Net profit margin | โ | โ |
Earnings per share | -0.30 | 91.67% |
EBITDA | -970.42K | 27.87% |
Effective tax rate | โ | โ |
Balance Sheet
Total assets
Total liabilities
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.45M | 8.71% |
Total assets | 5.09M | 1.68% |
Total liabilities | 717.49K | -42.82% |
Total equity | 4.37M | โ |
Shares outstanding | 3.80M | โ |
Price to book | 1.76 | โ |
Return on assets | -43.71% | โ |
Return on capital | -51.36% | โ |
Cash Flow
Net change in cash
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Net income | -1.00M | 26.50% |
Cash from operations | -1.17M | 65.55% |
Cash from investing | โ | โ |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -1.17M | -140.41% |
Free cash flow | -796.16K | 71.93% |
About
Founded
2016
Headquarters
Website
Employees
6
